AMS Home - Australasian Menopause Society

IMS 19th World Congress on Menopause

Missed Out? Join IMS2024 On Demand!

Learn more

Consumer Information

Workplaces

World Menopause Day 2024

Menopause Hormone Therapy (MHT) | Stay informed

About AMS

Learn more about the AMS

AMS Members

Learn more about Member benefits

Health Professionals

Resources for promotion of healthy ageing

Consumer Information

Including infographics, fact sheets and videos

Find an AMS Member

For an AMS Member who is right for you

Workplaces

Partnerships and workplace training

We would like to wish you all the best over the holiday season. Looking forward to working with you in 2025.

The AMS offices will be closed from Friday December 20, 2024, reopening on Monday January 6, 2025. If your matter is urgent, please contact us via phone on 03 7076 1930 as this will continue to be monitored. If you have a media enquiry, please contact Geoff Setty at This email address is being protected from spambots. You need JavaScript enabled to view it.

AMS Statement 15 July 2024

The Australasian Menopause Society (AMS) provides education to health professionals to improve the healthcare of women at perimenopause and after menopause.

The AMS welcomes discussion of menopause and efforts to improve access to appropriate care. However, we have recently become aware of spurious claims being made about menopause and hormone therapy by some health professionals on social media and in opinion pieces. These claims are presented as mainstream expert opinion, but some of them do not accord with current evidence-based guidelines.

Menopausal Hormone Therapy (MHT) discontinuation and shortages Dec 2024

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia.

Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

AMS Features

Members login to see more articles.

Menopausal Hormone Therapy (MHT) discontinuation and shortages November 2024

Australia Patch Shortages There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered... Read more
Australasian Menopause Society applauds Senate Inquiry Report

Thursday, 19 September 2024: The Australasian Menopause Society (AMS) has welcomed the ﬁndings of the Senate Inquiry into Menopause and... Read more
Severe menopause symptoms may take toll on brain health

With more than 24 million people globally living with dementia without a cure in sight, there is a lot of focus on ways to prevent and delay... Read more
Symptom Checker

About The Symptom Checker advises if you should see a doctor or care for yourself at home. It is designed for people in Australia. It can also help you find... Read more
Menopause Essentials Update 2024

19th World Congress on Menopause | Pre-congress course Menopause Essentials Update Friday October 18th 2024 13:30–18:00 This course is for all... Read more
Focus on less invasive treatments for heavy menstrual bleeding

On 13 June 2024 the Australian Commission on Safety and Quality in Health Care released national trend data in a new report suggesting that women may... Read more

AMS eLearning

The courses available here are in response to requests from many GPs for up to date evidence-based information and guidance in managing women’s midlife health issues including menopause.

AMS Member Access
The courses are available free for AMS Members.

Non AMS Member Access
Site registration is free of charge. Courses are available on a pay for enrolment basis through PayPal.

Go to AMS eLearning